Panadol junior

Selected form

Acetaminophen

Method of action: Analgesic, Anti-Inflammatory, Antipyretic, Pain Reliever

Treatment option: Period Pain, Backache, Pain, Sore Throat, Earache, Headache, Influenza, Toothache, Fever, Migraine

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Panadol junior

Quick Facts

Property	Description
Active ingredient	Acetaminophen (Paracetamol)
Form	Oral suspension, Syrup, Chewable tablets
Pharmacological class	Non-opioid Analgesic and Antipyretic
General purpose	Relief of pain and fever
Origin	Synthetic Aniline derivative

What Type of Medicine is Panadol junior?

Panadol junior is a dedicated oral pediatric preparation whose sole active compound is Acetaminophen, an entity universally recognized as Paracetamol. It is definitively classified as a Non-opioid Analgesic and Antipyretic medicine. This medicine is structurally distinct as a synthetic Aniline derivative with a centralized mechanism, contrasting with the peripheral effects of anti-inflammatory drugs. Panadol junior is specifically positioned within the market as an over-the-counter (OTC) option focused entirely on the needs of children, often featuring specific flavorings to enhance acceptance by its target age group.

Composition and Available Pediatric Forms

The active ingredient, Acetaminophen, is delivered to junior patients in various pediatric formulation formats designed to facilitate accurate administration and ease of swallowing. These forms commonly include low-concentration oral suspension, syrup, and palatable chewable tablets. The composition is engineered for its target audience, typically utilizing an aqueous vehicle for the liquid forms and appropriate solid excipients for the tablets, distinguishing it from adult formulations that require higher concentrations or standard solid forms. The monosemic (single active ingredient) nature of Panadol junior is a key differentiating factor, simplifying the therapeutic profile when managing common symptoms such as discomfort accompanying a feverish state. This indicates that the active component is a clinically recognized and reliable option for general relief in children.

General Purpose and Mechanism of Action

The overarching purpose of this medication is to provide general relief from the common symptoms of mild to moderate body discomfort and elevated temperature in children, representing a typical use scenario. It achieves this through a central mechanism involving two core principles: analgesia (pain relief) and antipyresis (fever reduction). By influencing the body's internal thermostat in the brain's thermoregulatory center, the medication modulates the elevated temperature set-point, while simultaneously reducing the perception of pain signals (antinociception), thereby restoring comfort to the patient.

Regulatory References

Acetaminophen: MedlinePlus Drug Information

What side effects are possible with Panadol junior?

Possible Side Effects and Safety Information

This section outlines possible side effects and key safety considerations as documented in official government regulatory information for medicines containing paracetamol (acetaminophen).

Serious Safety Restrictions

Regulatory documentation highlights the critical risk of severe liver damage (hepatotoxicity), which can be fatal, associated primarily with exceeding the recommended maximum dose (overdose). Because of this risk, it is strictly prohibited to use Panadol junior with any other medicine containing paracetamol or acetaminophen.

Documented Adverse Reactions

Adverse reactions are classified by regulatory authorities according to body system and frequency. The majority of individuals tolerate the medicine well at recommended doses.

System-Organ Class	Examples of Documented Reactions (Frequency)
Hepatobiliary Disorders	Severe liver failure (associated with overdose)
Skin and Subcutaneous Tissue Disorders	Rash, itching (Rare); Severe reactions like Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP) (Very Rare)
Blood and Lymphatic System Disorders	Thrombocytopenia (low platelet count), agranulocytosis (Rare)
Immune System Disorders	Anaphylaxis, angioedema (Rare)

General Safety Profile

When used as recommended, side effects are generally rare and mild. However, the most serious safety focus remains the acute risk of severe liver toxicity tied to total dosage. Caution is officially documented for use in patients with pre-existing severe liver or renal impairment. Regulatory classifications state that patients with known hypersensitivity to paracetamol are contraindicated from using this medicine.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of acetaminophen (Paracetamol) is a medical emergency. Severe toxicity is not immediately apparent, as the most serious consequences, such as Acute Liver Failure and Hepatic Necrosis, are often delayed.

Documented Manifestations and Severe Outcomes

Classification	Officially Documented Signs
Early Symptoms (First 24 hours)	Nausea, Vomiting, Loss of appetite (Anorexia), Pallor, Abdominal Pain. Symptoms may be absent, yet severe damage can progress.
Delayed Symptoms	Jaundice (yellowing of skin/eyes), pain in the upper right abdomen, and signs of hepatic encephalopathy.
Severe Outcomes	Acute Liver Failure, Hepatic Necrosis, Acute Renal Failure, and Death.

Mandatory Emergency Actions

Immediate medical intervention is essential due to the time-critical nature of treatment. The specific antidote, N-acetylcysteine (NAC), is most protective when administered quickly. Regulator-approved documentation emphasizes the following:

Seek immediate medical attention or contact a Poison Control Center immediately upon any suspicion of overdose, regardless of whether the child feels well.
Urgent hospitalization is required, especially if the person is unconscious, semiconscious, or not breathing.
Individuals with pre-existing severe hepatic impairment or chronic malnutrition are at increased risk of toxicity at potentially lower doses.

Therapeutic Uses of Panadol junior

What Panadol Junior Treats: Main Uses and Benefits

Managing Fever and Temperature-Related Distress

Panadol junior is primarily used for easing fever and is relevant for easing elevated body temperature in pediatric patients. It assists with managing symptoms related to systemic imbalance and helps address the acute symptomatic distress that often accompanies a feverish state. This is commonly used to help with symptomatic relief for localized discomforts, including headache, toothache, sore throat, and generalized body aches that are often associated with conditions presenting with systemic or localized discomfort.

“It assists with managing symptoms related to systemic imbalance and helps address the acute symptomatic distress that often accompanies a feverish state.”

The medication is relevant for easing symptoms that become more noticeable, such as during acute episodes of the common cold and flu or managing post-immunization fever and discomfort. It is applied in scenarios where additional management of discomfort is appropriate, especially when acute manifestations interfere with the child's daily functioning. This symptomatic relief contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

Quick Fact: Relief for Fever and Mild to Moderate Pain

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Panadol junior

The eligibility for Panadol junior (Acetaminophen/Paracetamol) is strictly defined by regulatory authorities based on age, health status, and concurrent medication use.

Eligibility Scope

Classification	Population Rule
Approved Age	Children and Infants aged 2 months and over are permitted for use under standard label conditions.
Conditional Use	Infants aged 2 to 3 months require use to be limited to specific conditions, such as post-immunization fever, or meeting specific weight and gestational criteria.
Absolute Contraindications	Use is contraindicated in patients with known hypersensitivity to acetaminophen or any component of the formulation.
Non-Eligibility	Patients with severe hepatic impairment or severe active liver disease must not use this medicine.
Restriction	Concurrent use of any other product containing acetaminophen is prohibited.

Condition-Specific Eligibility

Use requires caution in patients with renal impairment, hepatic impairment (not severe), chronic malnutrition, or severe hypovolemia. For individuals who are pregnant or breastfeeding, the label directs consulting a health professional before use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Panadol junior, which contains paracetamol (acetaminophen), has established interactions primarily centered on the risk of overdose and its effect on certain blood-thinning medicines.

Critical Restriction (Risk of Overdose): The most important instruction is to never combine this product with any other medicine, prescription or over-the-counter, that also contains paracetamol or acetaminophen. Paracetamol is a common ingredient found in many cold, flu, and pain relief remedies. Taking multiple products containing this ingredient can lead to an excessive total daily dose, which carries a significant risk of severe, potentially fatal, liver damage.

Interactions with Blood Thinners: If the person is taking Warfarin or similar anticoagulant medicines used to thin the blood, caution is advised. Regular, daily use of paracetamol over a prolonged period may increase the effect of these anticoagulants, thereby increasing the risk of bleeding. Occasional, short-term use at recommended doses is generally not associated with this clinically significant interaction. It is important to consult a healthcare professional regarding the safe use of paracetamol if blood thinners are being taken.

Other Factors: Certain medicines can affect how paracetamol is absorbed or broken down by the body. This includes medicines used to treat nausea, such as metoclopramide, which can increase absorption, and certain medicines that slow stomach emptying, which can decrease absorption.

Mechanism of Action

Central Targeting of Thermoregulation and Nociceptive Pathways

The primary action of the drug occurs within the Central Nervous System (CNS), where it targets the Cyclooxygenase (COX) enzymes found predominantly in the brain's hypothalamus and spinal cord. This action involves hindering the synthesis of Prostaglandin E2 (PGE2), a key signaling molecule that influences the body's internal temperature and nociceptive signaling. By modulating this molecular step, the drug initiates a cascade resulting in the adjustment of the elevated thermoregulatory set-point and limits the activity of nociceptive pathways.

Modulation via Endogenous Inhibitory Pathways

The antinociceptive consequence is compounded by the action of an active metabolite, AM404, which engages the endogenous inhibitory pathways. This metabolite acts upon TRPV1 and CB1 receptors, which are integral components of the endocannabinoid system. This potentiation modulates the activity of descending inhibitory pathways that project from the brainstem to the spinal cord, influencing nociceptive signal transmission through a two-component mechanism. This central focus distinguishes its action, as its inhibitory effect on COX is significantly diminished by the high peroxide concentrations present at sites of peripheral inflammation.

Dosage and Administration Information

Administration Route and Dosing Basis

Panadol junior, which contains the active ingredient acetaminophen (Paracetamol), is primarily administered via the oral route in liquid or solid forms such as suspensions, syrups, or chewable tablets. Rectal administration using suppositories is an alternative route approved for use when oral intake is compromised.

The determination of the appropriate amount to give is based on the child's body weight or corresponding age group. The single quantity administered typically falls within the range of 10 to 15 mg/kg of the child's weight. For children under 2 years of age, administration often requires prior consultation with a doctor as a matter of labeling constraint.

Frequency and Procedural Constraints

The administration schedule is strictly intermittent. A minimum interval of four hours must elapse between any two successive doses. The total administration is limited to a maximum of four doses in any 24-hour period, a rule that defines the acceptable frequency pattern. For non-prescription use, the official duration is generally limited to three days for fever or 5 days for pain.

Proper usage necessitates the use of the measuring device supplied with the product to ensure dose accuracy, and liquid formulations must be shaken well before measurement. A fundamental rule governing the use protocol is that the patient must not be given any other product, over-the-counter or prescription, that contains acetaminophen/paracetamol during the course of use.

Recent Clinical Evidence

Research evidence / Overview of Studies for Panadol Junior

Evidence for Research on Elevated Temperature Patterns

The research base has utilized numerous Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews to explore how symptoms change over defined time intervals. These studies focus on the pediatric population and are applied in research contexts involving temporary physiological imbalance. The studies monitored outcomes related to systemic or functional imbalance, such as the evolution of temperature patterns and patient-reported physical discomfort during periods of increased symptom activity.

Research highlights changes measured during the study period, where patterns related to changes in temperature were reported when compared against a non-treatment (placebo) group or other study comparators. However, the research exploring short-term symptom changes often has limited follow-up durations, meaning observations are primarily restricted to the acute episode.

Evidence for Research on Acute Physical Discomfort

Research examined conditions associated with acute or disruptive episodes, such as headache, toothache, post-procedural discomfort, and traumatic injury, by conducting comparative Randomized Controlled Trials (RCTs) and Systematic Reviews. The research explored short-term symptom changes, focusing on patient-reported outcomes describing perceived discomfort and monitoring the need for additional pain relief medication.

Studies focusing on episodes where symptoms become more noticeable reported patterns related to measured changes in pain intensity in the observed populations. The evidence base related to acute discomfort is large within scientific documentation. These trials primarily apply to episodic or acute changes and do not offer insight into discomfort lasting longer than three months.

What is Still Uncertain About the Research Evidence

Follow-up durations were limited in many initial trials, often to a median of 48 hours, which was sufficient to study acute changes. Consequently, long-term effects are not fully established by the core clinical trials. The research has not included randomized controlled trials exploring the effect on conditions involving periods of heightened symptoms that extend beyond the acute phase, such as chronic non-cancer pain in children and adolescents. Data for certain groups, such as children who are overweight or obese, also remain insufficient for a comprehensive understanding.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Panadol junior (FAQ)

Q: Can I take Panadol junior with my daily multivitamin?

Drug information sources indicate there are no known major interactions between Panadol junior and many standard multivitamins. However, product information suggests that high zinc intake might interfere with Panadol junior absorption.

It is important to discuss all medications and supplements with a healthcare provider or pharmacist. For specific advice on timing and separation of medications, a pharmacist or physician should be consulted to ensure safety and optimal benefit.

Q: How long does it take for Panadol junior to start relieving pain?

Clinical data suggests that pain relief may begin within 30 to 45 minutes for many individuals. Panadol junior is formulated for rapid absorption, but its mechanism of action is distinct from over-the-counter medications.

It's important to remember that individual response times to medication can vary, so consult the product information for expected results.

Q: What should I do if I miss a dose of Panadol junior?

The recommended course of action for a missed dose is typically detailed in the official product labeling, and usually advises to take it as soon as remembered, unless it is near the time of the next scheduled dose.

It is generally advised to avoid taking two doses at once to make up for a missed dose.

To minimize the risk of side effects, it is essential to follow the specific instructions from a healthcare provider or the product label. For specific directions regarding missed doses, particularly multiple doses, consult a qualified healthcare professional.

How should Panadol junior be stored and disposed of?

Official Storage and Disposal Requirements

This information is based on authoritative government regulatory labeling for paracetamol oral suspension and must be followed to maintain product integrity and safety.

Requirement Area	Regulatory Statement
Temperature & Protection	Store below the specified maximum temperature (e.g., 25 C or 30 C). Do not refrigerate or freeze, and protect from light and moisture.
Stability & Packaging	Keep the medicine in its original container. Do not use the suspension after the stated expiry date or after the designated stability period following first opening (e.g., 1 month).
Child Safety	Always keep the product strictly out of the sight and reach of children.
Disposal	Do not dispose of unused or expired medicine via wastewater or household trash. Return the product to a pharmacist or official collection point for proper environmental protection.